Search results for: 'research area cell cycle rad51'
- BA5856 AcazicolceptSummary: Azacicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell co-stimulator/antagonist.
- BA5858 SolitomabSummary: Solitomab (AMG110) is a bispecific anti- and anti-epithelial cell adhesion molecule antibody.
- BA6019 PivekimabSummary: Pivekimab is available for the study of Bastoid Plasmacytoid Dendritic Cell Neoplasms (BPDCN).
- BA6156 NSC622608Summary: NSC622608 is a T cell activation V structural domain Ig inhibitor ligand.
- BA6911 N-BromoacetamideSummary: N-Bromoacetamide irreversibly deactivates sodium channels on the cytoplasmic surface of cell membranes.
- BA3357 PZ703bSummary: PZ703b is a degradative agent that induces apoptosis and inhibits cancer cell proliferation.
- BA3369 StauprimideSummary: Stauprimide is an astaxanthin analog that promotes embryonic stem cell (ESC) differentiation.
- BA4199 Hsp90-Cdc37-IN-1Summary: Hsp90-Cdc37-IN-1 is an interaction disruptor that inhibits cell migration and reverses drug resistance.
- C8201 BODIPY-CholesterolSummary: BODIPY-cholesterol is a lipophilic and cell permeable cholesterol analog with a fluorescent BODIPY moiety.
- N2031 PiceatannolSummary: p56lck/Syk inhibitor